⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Levi & Korsinsky Urges Regeneron Pharmaceuticals, Inc. (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Calls Attention to Class Action Filed Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
REGN INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
accessnewswire.com
REGN
Recover Investment Losses: Class Action Initiated Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Pomerantz LLP Informs Investors of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN
Pomerantz LLP Calls Attention to Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN